Skip to main content
. 2016 Apr 27;71(8):2234–2240. doi: 10.1093/jac/dkw127

Table 1.

Demographics of patients in the prophylaxis study

Age (years), median (range) 44.23 (12.80–65.75)
Female, n (%) 84 (44.9)
Disease, n (%)
 AML 78 (41.7)
 ALL 34 (18.2)
 CML 30 (16.0)
 myelodysplasia 30 (16.0)
 biphenotypic leukaemia 2 (0.01)
 lymphoma 13 (8.49)
Proven, probable or presumptive fungal infection, n (%) 10 (6.95)